| Document And Entity Information | Nov. 07, 2022 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Nov. 07, 2022 |
| Entity Registrant Name | DAY ONE BIOPHARMACEUTICALS, INC. |
| Entity Central Index Key | 0001845337 |
| Entity Emerging Growth Company | true |
| Securities Act File Number | 001-40431 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 83-2415215 |
| Entity Address, Address Line One | 2000 Sierra Point Parkway, Suite 501 |
| Entity Address, City or Town | Brisbane |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94005 |
| City Area Code | (650) |
| Local Phone Number | 484-0899 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Ex Transition Period | false |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | DAWN |
| Security Exchange Name | NASDAQ |
